Aria Pharmaceuticals
Palo Alto
About Aria Pharmaceuticals
Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can't wait. That's why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we've shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2021)
- Website: ariapharmaceuticals.com
- Phone: (650) 382-2605
Industries & Categories
Artificial Intelligence (AI), Big Data, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aria-pharmaceuticals-109638 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.